Picture of Immuno-Biological Laboratories logo

4570 — Immuno-Biological Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Table: Immuno Biological Lab - 9-MTH group results

Feb 4 (Reuters)- 
             Immuno Biological Laboratories Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2021        Dec 31, 2020      Mar 31, 2022  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            448 mln             414 mln           770 mln    
                 (+8.1 pct)          (+6.3 pct)        (+27.7 pct)  
  Operating     loss 136 mln        loss 230 mln      loss 107 mln  
  Recurring     loss 232 mln        loss 299 mln      loss 154 mln  
  Net           loss 243 mln        loss 303 mln      loss 162 mln  
  EPS          loss 26.14 yen      loss 32.61 yen    loss 17.42 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Immuno Biological Laboratories Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T

Recent news on Immuno-Biological Laboratories

See all news